Join to View Full Profile
348 S Maple AveGlen Rock, NJ 07452
Phone+1 201-652-6060
Fax+1 201-652-1882
Dr. Dosik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineResidency, Dermatology, 1997 - 2000
New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1996 - 1997- New York University School of MedicineClass of 1996
Certifications & Licensure
NJ State Medical License 2000 - 2025
NY State Medical License 1997 - 2025
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers Start of enrollment: 2010 Jul 01
- PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects Start of enrollment: 2011 Feb 01
- 24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- A 6-month, Multi-center, Double-blind, Controlled Study to Evaluate the Effect of a Biofilm Disrupting Acne Cream on Mild-to-Moderate Facial Acne in Female Volunteer S...Allyson Marshall-Hudson, Michael Tuley, Maureen Damstra, Jonathan S Dosik, Matthew F Myntti
The Journal of Clinical and Aesthetic Dermatology. 2023-04-01 - 2 citationsContact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers.Jonathan Dosik, David L Cutler, Jane Fang, Laura Padullés
JID Innovations. 2023-03-01 - 2 citationsSkin Irritation and Sensitization Potential of Fixed-Dose Combination of Diclofenac 1% and Menthol 3% Topical Gel: Results of Two Phase I Patch Studies.Dongzhou Jeffery Liu, Agron Collaku, Jonathan S. Dosik
Drug Research. 2016-11-25
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
